Search Options Stock News and Analysis from Schaeffer's

Wall Street Brushed Off Inflation Data This Week

https://www.schaeffersresearch.com/content/news/2023/10/13/wall-street-brushed-off-inflation-data-this-week

10/13/2023 2:29 PM

The devastating Israel-Hamas war provided a worrisome geopolitical backdrop this week, causing oil prices to rise and U.S. Treasury yields to make large, volatile swings. Stocks, for the most part,...

Analysts Target Biotech Name on Buyout Buzz

https://www.schaeffersresearch.com/content/options/2023/10/09/analysts-target-biotech-name-on-buyout-buzz

10/9/2023 3:03 PM

Mirati Therapeutics Inc (NASDAQ:MRTX) stock is dropping today, after news that Bristol-Myers Squibb (BMY) will acquire the company for up to $5.8 billion. MRTX was down 5.2% at $57.09 at last glance,...

Pharma Stock Nears 2-Year Low on Multi-Billion Dollar Deal

https://www.schaeffersresearch.com/content/news/2023/10/09/pharma-stock-nears-2-year-low-on-multi-billion-dollar-deal

10/9/2023 2:10 PM

Shares of major pharmaceutical name Bristol-Myers Squibb Co (NYSE:BMY) are 0.2% lower at $56.54 at last glance, and touched a nearly two-year low of $55.70, after the company agreed to acquire Mirat...

Bearish Bet on Pharma Stock Doubled Investors' Money

https://www.schaeffersresearch.com/content/options/2023/09/18/bearish-bet-on-pharma-stock-doubled-investors-money

9/18/2023 2:32 PM

Subscribers to Schaeffer's Leverage Trader service more than doubled their investment with our Bristol-Myers Squibb Co (NYSE:BMY) September 63 put recommendation, all in in just two weeks. Below, w...

Multiple Reasons to Keep Off This Pharma Stock

https://www.schaeffersresearch.com/content/analysis/2023/08/30/multiple-reasons-to-keep-off-this-pharma-stock

8/30/2023 1:42 PM

Bristol-Myers Squibb Co (NYSE:BMY) is down 0.7% to trade at $62.42 at last check, after the Biden administration included the pharmaceutical name's blood thinner Eliquis in its list of 10 prescriptio...

PEOPLE ALSO SEARCH FOR